Head and Neck-Journal for the Sciences and Specialties of the Head and

Papers
(The H4-Index of Head and Neck-Journal for the Sciences and Specialties of the Head and is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Issue Information49
49
Waldeyer ring microbiome in relation to chemoradiation‐induced oral mucositis in patients with nasopharyngeal carcinoma43
Carboplatin and paclitaxel after anti‐PD‐1 or anti‐PD‐L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck32
Financial (dis)incentives to surgical management of head and neck cancer care32
Causes and impact of delays during the COVID‐19 pandemic on head and neck cancer diagnosis31
Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies30
Selection of an Endoscopic Endonasal or Transoral Approach to the Infratemporal Fossa30
Noise level and surgeon stress during thyroidectomy in an endocrine surgery operating room29
The Efficacy of Liquid Biopsy of Total cfDNA for Predicting Systemic Metastasis in Japanese Patients With Oral Squamous Cell Carcinoma29
Risk of Occult Contralateral Neck Metastasis in Early‐Stage HPV ‐Related Lateralized Cancer of the Base of the Tongue29
Chemoprevention of oral cancer: A review and future perspectives28
Fluconazole for Preventing Radiation‐Induced Oral Mucositis: A Randomized Controlled Trial28
Exploratory Research: Patient‐Reported Factors Contributing to Decreased Oral Intake During Radiotherapy in Head and Neck Cancer27
Expiratory Muscle Strength Training in Head and Neck Cancer Survivors With Radiation‐Associated Dysphagia: Results of a Pilot Prospective Trial27
Risk factors associated with prognosis of patients with medication‐related osteonecrosis of the jaw26
A randomized study comparing the nutritional effects of radiotherapy with cetuximab versus cisplatin in patients with advanced head and neck cancer26
Clinical outcome of salvage surgery in patients with recurrent oral cavity cancer: A systematic review and meta‐analysis25
The Persistence of Racial Representation Disparity in Head and Neck Cancer Clinical Trials in the United States: A Temporal Analysis of 20 Years of Data25
Issue Information25
Cost‐Effectiveness of 18F ‐Choline PET / CT Ver25
Prognosis After Discontinued Treatment due to Immune‐Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma24
Issue Information24
Oncological Outcomes of Salvage Oropharyngectomy in Irradiated Neck for Recurrent or Metachronous Squamous Cell Carcinoma24
0.22252321243286